Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Iqvia Holdings Inc    IQV

IQVIA HOLDINGS INC

(IQV)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/09/2019 09/10/2019 09/11/2019 09/12/2019 09/13/2019 Date
151.87(c) 150.41(c) 150.23(c) 150.73(c) 151.35(c) Last
1 947 843 2 097 064 1 597 320 1 670 186 1 467 163 Volume
-1.43% -0.96% -0.12% +0.33% +0.41% Change
More quotes
Financials (USD)
Sales 2019 11 079 M
EBIT 2019 2 113 M
Net income 2019 343 M
Debt 2019 9 426 M
Yield 2019 -
Sales 2020 11 908 M
EBIT 2020 2 311 M
Net income 2020 525 M
Debt 2020 9 307 M
Yield 2020 -
P/E ratio 2019 88,0x
P/E ratio 2020 56,2x
EV / Sales2019 3,53x
EV / Sales2020 3,27x
Capitalization 29 649 M
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial... 
More about the company
Surperformance© ratings of Iqvia Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on IQVIA HOLDINGS INC
08/26IQVIA : Recommends Shareholders Reject “Mini-Tender” Offer by TRC Ca..
BU
08/21IQVIA : to Participate in Baird 2019 Global Healthcare Conference on September 4..
BU
08/15IQVIA : Launches Patient Portal to Transform the Clinical Trial Experience
BU
08/13IQVIA HOLDINGS INC. : Entry into a Material Definitive Agreement, Creation of a ..
AQ
08/08IQVIA : Announces Repurchase of Common Stock
BU
08/07Hedge fund Hoplite Capital plans to shut down - letter
RE
08/05IQVIA : Named Real World Evidence Leader
BU
08/01IQVIA : 's Cynthia Verst Honored on 2019 PharmaVOICE 100 List
BU
07/30IQVIA : Announces Pricing of Offering of Senior Notes
BU
07/29IQVIA HOLDINGS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
02:48aA Plan to Fight Hep C -- WSJ
DJ
09/03Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
RE
08/29GLOBAL MARKETS LIVE : Dell, United Airlines, UBS, Apple…
08/28U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight
RE
08/28US Judge Mostly Sets Aside Jury Ruling on Repatha Patents -Reuters
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart IQVIA HOLDINGS INC
Duration : Period :
Iqvia Holdings Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 173,37  $
Last Close Price 151,35  $
Spread / Highest target 28,2%
Spread / Average Target 14,5%
Spread / Lowest Target -13,4%
EPS Revisions
Managers
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
Jim Berkshire Senior Vice President-Business Operations
Michael R. McDonnell Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
Margaret Keegan President-Clinical Operations
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC30.28%29 649
LONZA GROUP32.78%25 385
CELLTRION, INC.--.--%18 337
INCYTE CORPORATION20.19%16 438
EXACT SCIENCES CORPORATION69.11%13 817
SEATTLE GENETICS, INC.24.66%11 927